Ligand Pharmaceuticals Inc. (OQ:LGND)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for LGND within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 29th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 26/19 Dec 20/19 Korenberg Matthew E Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -979 $105.87
Dec 26/19 Dec 20/19 Korenberg Matthew E Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,305  
Dec 26/19 Dec 20/19 Korenberg Matthew E Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,135 $105.87
Dec 26/19 Dec 20/19 Korenberg Matthew E Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,674  
Dec 26/19 Dec 20/19 Berkman Charles S Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -546 $105.87
Dec 26/19 Dec 20/19 Berkman Charles S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,335  
Dec 26/19 Dec 20/19 Berkman Charles S Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -585 $105.87
Dec 26/19 Dec 20/19 Berkman Charles S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,693  
Dec 26/19 Dec 20/19 Foehr Matthew W Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,444 $105.87
Dec 26/19 Dec 20/19 Foehr Matthew W Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,913  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LGND within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 29th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 26/19 Dec 20/19 Korenberg Matthew E Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -979 $105.87
Dec 26/19 Dec 20/19 Korenberg Matthew E Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,305  
Dec 26/19 Dec 20/19 Korenberg Matthew E Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,135 $105.87
Dec 26/19 Dec 20/19 Korenberg Matthew E Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,674  
Dec 26/19 Dec 20/19 Berkman Charles S Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -546 $105.87
Dec 26/19 Dec 20/19 Berkman Charles S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,335  
Dec 26/19 Dec 20/19 Berkman Charles S Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -585 $105.87
Dec 26/19 Dec 20/19 Berkman Charles S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,693  
Dec 26/19 Dec 20/19 Foehr Matthew W Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,444 $105.87
Dec 26/19 Dec 20/19 Foehr Matthew W Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,913  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $LGND

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Vir Biotechnology (OQ:VIR)
Seattle Genetics (OQ:SGEN)